Axcelis Technologies reports developments tied to its role as a supplier of ion implantation systems and process applications for semiconductor manufacturing. Company updates commonly cover quarterly results, demand trends across memory, power, compound semiconductor and mature-node markets, and the performance of its customer support and installed-base services business.
News also includes technical participation at semiconductor industry conferences, lifecycle support for Purion-based implant platforms, sustainability targets for greenhouse gas emissions, investor-conference activity and governance changes such as finance leadership transitions. The recurring business context centers on equipment used in integrated-circuit fabrication and aftermarket services including spare parts, upgrades, maintenance and training.
Axcelis Technologies (Nasdaq: ACLS) has announced the appointment of David Ryzhik as Senior Vice President of Investor Relations and Corporate Strategy, effective July 2024. Ryzhik brings over 20 years of experience in investor relations and finance, including roles at MKS Instruments and Susquehanna International Group. He will succeed Doug Lawson, who plans to retire but will remain as a Senior Advisor until July 2025. Lawson has had a 15-year tenure with Axcelis, holding various executive roles and significantly contributing to corporate marketing and strategy. The transition aims to leverage Ryzhik's extensive experience to further Axcelis' growth objectives.
Axcelis Technologies (NASDAQ: ACLS), a key supplier of ion implantation solutions for the semiconductor industry, has inaugurated new service offices in Chitose, Hokkaido, and Kumamoto, Kyushu, Japan. These offices, which opened in June 2024, aim to enhance support for the company's expanding customer base in Japan. Axcelis President and CEO Russell Low emphasized the company's commitment to innovation and market share growth. Charles Pieczulewski, Axcelis Japan Country Manager, noted the strategic positioning of the new offices to improve support for Purion ion implant equipment and foster relations with both Silicon (Si) and Silicon Carbide (SiC) semiconductor power device customers, enabling advancements in logic production capacity.
Axcelis Technologies (NASDAQ: ACLS) has announced its participation in the 16th Annual CEO Investor Summit 2024, scheduled for July 10th at the St. Regis Hotel in San Francisco, CA.
Axcelis, a key supplier of ion implantation solutions for the semiconductor industry, will present at the event. Presentation materials will be available on the company's investor webpage.
Axcelis Technologies (Nasdaq: ACLS) will host a hybrid Investor Event on July 11, 2024, at the St. Regis Hotel, San Francisco. The event, aimed at the investment community, will run from 8 a.m. to 11 a.m. PT, with presentations starting at 9 a.m. PT. These presentations will cover Axcelis' business, growth strategy, and financial outlook. All executive officers will be present. Interested investors can attend in person or via a live audio webcast. More details and registration links are available on Axcelis’ website.
Axcelis Technologies, Inc. (NASDAQ: ACLS) announced its participation in several upcoming investor conferences, providing a platform for management to engage with investors and discuss the company's offerings for the semiconductor industry.
Axcelis Technologies, Inc. (ACLS) announced financial results for Q1 2024, reporting revenue of $252.4 million, a gross margin of 46%, and EPS of $1.57. Despite revenue decline from the previous quarter, the company exceeded guidance and highlighted growth in the implant intensive power device segment and shipments to China. The CEO mentioned continued strong execution and product success, while the CFO emphasized robust cash flow and a positive outlook for 2024.
Summary not available.
Summary not available.
Summary not available.
Summary not available.